The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 331:134-135 July 14, 1994 Number 2
NextNext

Hepatotoxicity of Saccharin

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
To the Editor: Saccharin is not known to alter liver function1,2,3,4. We report on a patient who had elevated serum concentrations of liver enzymes after the oral administration of three different drugs, of which saccharin was the only common constituent. Reexposure to pure saccharin supported its role in the pathogenesis of liver damage in this patient.

A 70-year-old woman being evaluated for chronic fatigue was found to have increased levels of serum aspartate aminotransferase (306 U per liter), alanine aminotransferase (247 U per liter), {gamma}-glutamyltransferase (1000 U per liter), and alkaline phosphatase (478 U per liter). The patient had . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.